2018
DOI: 10.1021/acs.jmedchem.8b00540
|View full text |Cite
|
Sign up to set email alerts
|

Pseudomonas aeruginosa Quorum Sensing Systems as Drug Discovery Targets: Current Position and Future Perspectives

Abstract: Antimicrobial resistance (AMR) is a serious threat to public health globally, manifested by the frequent emergence of multidrug resistant pathogens that render current chemotherapy inadequate. Health organizations worldwide have recognized the severity of this crisis and implemented action plans to contain its adverse consequences and prolong the utility of conventional antibiotics. Hence, there is a pressing need for new classes of antibacterial agents with novel modes of action. Quorum sensing (QS), a commun… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
128
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 121 publications
(129 citation statements)
references
References 138 publications
1
128
0
Order By: Relevance
“…Since bacterial communities coordinate their pathogenic activities including biofilm development through cell-cell communication (quorum sensing, QS) 5,18 using small diffusible signal molecules, disruption of QS interferes with biofilm formation and maturation. [19][20][21][22][23] However, while there are combination formulations in the clinic which use antibiotics and β-lactamase inhibitors (e.g. Tazocin®, Unasyn® Augmentin®), none to date have utilised QS inhibitors (QSIs) as biofilm disrupting agents.…”
Section: Introductionmentioning
confidence: 99%
“…Since bacterial communities coordinate their pathogenic activities including biofilm development through cell-cell communication (quorum sensing, QS) 5,18 using small diffusible signal molecules, disruption of QS interferes with biofilm formation and maturation. [19][20][21][22][23] However, while there are combination formulations in the clinic which use antibiotics and β-lactamase inhibitors (e.g. Tazocin®, Unasyn® Augmentin®), none to date have utilised QS inhibitors (QSIs) as biofilm disrupting agents.…”
Section: Introductionmentioning
confidence: 99%
“…28,29 These new therapies target essentially the prevention of virulence factors production by pathogens, rather than their survival, and they also aim to thwart the regulatory mechanisms controlling their expression. 19,30 In addition, by targeting essential virulence determinants, the emergence and spread of bacterial resistance will be reduced due to decreased selective pressure and the natural microbiota will be preserved. In line with this scenario, the current study was designed to explore new anti-virulence agents to fight against the multidrug-resistant P. aeruginosa that is responsible for many different infections.…”
Section: Discussionmentioning
confidence: 99%
“…Since for P. aeruginosa infections QS is the master regulator involved in the expression of many virulence factors such as phenazines, exoproteases (elastase, alkaline protease), siderophores, and toxins among others, its inhibition represents a valuable adjuvant therapy that might be used to potentiate the activity of the available antibiotics applied to handle early P. aeruginosa infections. 19,30 In the last five years there was a large amount of published investigations reporting natural products highlighting their potential in targeting bacterial virulence factors. 21 Several plant-derived compounds that belong to alkaloids, organosulfurs, coumarins, flavonoids, phenolic acids, phenylpropanoids, terpenoids among other chemical classes have been found to be active against pyocyanin pigment production.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations